Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mazisotine in Adult Participants With Diabetic Peripheral Neuropathic Pain
NCT06074562Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of ly3556050 in diabetic polyneuropathy (DPN), sponsored by Eli Lilly and Company. Started Oct 2023; status: completed.
02
Drugs
ly3556050
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT06074562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06074562.